What's the difference between lung adenocarcinoma and lung squamous cell carcinoma? Evidence from a retrospective analysis in a cohort of Chinese patients

被引:22
|
作者
Wang, Wen [1 ]
Liu, Hui [1 ]
Li, Guoli [2 ,3 ,4 ,5 ]
机构
[1] Hunan Normal Univ, Hunan Prov Peoples Hosp, Dept Cardiothorac Surg, Affiliated Hosp 1, Changsha, Peoples R China
[2] Hunan Normal Univ, Hunan Prov Peoples Hosp, Dept Nephrol, Affiliated Hosp 1, Changsha, Peoples R China
[3] Hunan Normal Univ, Hunan Prov Peoples Hosp, Lab Kidney Dis, Affiliated Hosp 1, Changsha, Peoples R China
[4] Changsha Clin Res Ctr Kidney Dis, Changsha, Peoples R China
[5] Hunan Clin Res Ctr Chron Kidney Dis, Changsha, Peoples R China
来源
关键词
lung adenocarcinoma; lung squamous cell carcinoma; clinicopathologic characteristics; radiological features; laboratory data; PLATELET COUNT; CANCER; PROGNOSIS;
D O I
10.3389/fendo.2022.947443
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
BackgroundLung adenocarcinoma (LUAD) and lung squamous cell carcinoma (LUSC) are the two most common subtypes of lung cancer. Previously, they were categorized into one histological subtype known as non-small cell lung cancer (NSCLC) and often treated similarly. However, increasing evidence suggested that LUAD and LUSC should be classified and treated as different cancers. But yet, detailed differences in clinical features between LUAD and LUSC have not been well described. MethodsA cohort of 142 Chinese patients with 111 LUAD and 31 LUSC cases were consecutively enrolled from April 2019 to October 2020 in Hunan Provincial People's Hospital. The clinical features of the patients were retrospectively analyzed and compared in the terms of general information, clinicopathologic characteristics, imaging findings and laboratory data. ResultsIn comparison with LUAD, LUSC patients had a significantly higher proportion of males, smokers, drinkers, higher-stage cases. The mean tumor size in LUSC patients was significantly larger than that in LUAD patients. Compared with LUAD patients, more of patients with LUSC had cough, fever and abundant sputum symptoms. Besides that, more bacterial infections and fungal infections were found in LUSC patients than that in LUAD patients. Imaging data shows that ground-glass opacity and patchy shadows in radiological films were more frequent in LUAD patients than that in LUSC patients. In addition to initial laboratory data, LUSC patients had higher levels of leukocytes, platelets, and creatinine that of LUAD patients. ConclusionsTogether, these results suggested that there exist distinct differences between LUAD and LUSC subtypes; LUSC may be a more malignant type in comparison with LUAD. Our findings may have potential implications in clinical settings. However, further multicenter studies are needed to validate these findings in a larger sample size.
引用
收藏
页数:9
相关论文
共 50 条
  • [41] Comparisons of the clinicopathological features and survival outcomes between lung cancer patients with adenocarcinoma and squamous cell carcinoma
    Fukui T.
    Taniguchi T.
    Kawaguchi K.
    Fukumoto K.
    Nakamura S.
    Sakao Y.
    Yokoi K.
    General Thoracic and Cardiovascular Surgery, 2015, 63 (9) : 507 - 513
  • [42] Analysis of HYAL3 gene mutations in Chinese lung squamous cell carcinoma patients
    Zhang, Rong-xin
    Zhu, Jin-hai
    Fan, Jiang
    Ji, Xiao-qi
    TUMORI, 2013, 99 (01) : 108 - 112
  • [43] Serum proteomic analysis of lung squamous cell carcinoma patients
    Kuribayashi, Hidehiko
    Seike, Masahiro
    Okano, Tetsuya
    Soeno, Chie
    Yoshimura, Akinobu
    Kudoh, Shoji
    Gemma, Akihiko
    CANCER RESEARCH, 2009, 69
  • [44] Serum proteomic analysis of lung squamous cell carcinoma patients
    Kuribayashi, Hidehiko
    Seike, Masahiro
    Okano, Tetsuya
    Soeno, Chie
    Yoshimura, Akinobu
    Kudoh, Shoji
    Gemma, Akihiko
    JOURNAL OF THORACIC ONCOLOGY, 2009, 4 (09) : S914 - S914
  • [45] Identification of immunohistochemical markers for distinguishing lung adenocarcinoma from squamous cell carcinoma
    Zhan, Cheng
    Yan, Li
    Wang, Lin
    Sun, Yang
    Wang, Xingxing
    Lin, Zongwu
    Zhang, Yongxing
    Shi, Yu
    Jiang, Wei
    Wang, Qun
    JOURNAL OF THORACIC DISEASE, 2015, 7 (08) : 1398 - +
  • [46] Comprehensive Profiling of Genomic and Transcriptomic Differences between Risk Groups of Lung Adenocarcinoma and Lung Squamous Cell Carcinoma
    Zengin, Talip
    Onal-Suzek, Tugba
    JOURNAL OF PERSONALIZED MEDICINE, 2021, 11 (02): : 1 - 28
  • [47] Identification of differentially expressed genes between lung adenocarcinoma and lung squamous cell carcinoma by gene expression profiling
    Lu, Chaojing
    Chen, Hezhong
    Shan, Zhengxiang
    Yang, Lixin
    MOLECULAR MEDICINE REPORTS, 2016, 14 (02) : 1483 - 1490
  • [48] The role of SOX2 in small cell lung cancer, lung adenocarcinoma and squamous cell carcinoma of the lung
    Karachaliou, Niki
    Rosell, Rafael
    Viteri, Santiago
    TRANSLATIONAL LUNG CANCER RESEARCH, 2013, 2 (03) : 172 - 179
  • [49] The Global Landscape of Lung Squamous Cell Carcinoma, Lung Adenocarcinoma, Small Cell Lung Cancer Incidence in 2020
    Wang, J.
    Wang, M.
    JOURNAL OF THORACIC ONCOLOGY, 2023, 18 (11) : S52 - S53
  • [50] A COMPARISON OF CLINICOPATHOLOGIC FEATURES AND SURVIVAL OUTCOMES BETWEEN THE LUNG CANCER PATIENTS WITH ADENOCARCINOMA AND SQUAMOUS CELL CARCINOMA: STAGE I DISEASE OF SQUAMOUS CELL CARCINOMA IS THERE?
    Fukui, Takayuki
    Sakao, Yukinori
    Taniguchi, Tetsuo
    Usami, Noriyasu
    Kawaguchi, Koji
    Ishiguro, Futoshi
    Nakamura, Shota
    Yokoi, Kohei
    JOURNAL OF THORACIC ONCOLOGY, 2013, 8 : S626 - S626